A team of Mayo Clinic pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis, a rare kidney disease of unknown pathogenesis and poor outlook—nearly half of all patients end up on dialysis within four...
Mayo Clinic Laboratory and pathology research roundup: July 5 - Insights
This week’s research roundup features: The publication impact of the first 100 THOR Network publications by bibliometric and social network analyses.
Mayo Clinic Laboratory and pathology research roundup: February 21 - Insights
This week's Research Roundup features: Predicting amyloid PET and tau PET stages with plasma biomarkers.
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 13 - Insights
This week’s Research Roundup highlights how the DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN.
Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury. Based on the etiology of MPGN, Drs. Sethi and Fervenza proposed a new histologic classification of MPGN into Ig/IC-mediated MPGN and complement-mediated...
Surprises in Coagulation Testing - Insights
In this “Hot Topic,” William Nichols, M.D., presents a case study that demonstrates how pre- and postanalytic variables of the patient and blood samples can have confounding effects on the laboratory evaluation of coagulation disorders.
ACHE 2017 Congress on Healthcare Leadership Live Blog - Insights
Andy Cousin, FACHE, Director of Product Management and Marketing for Mayo Medical Laboratories, is attending this year's ACHE Congress on Health Care Leadership conference in Chicago. He will be sharing his thoughts and photos from the...
WuXi AppTec Group and Mayo Clinic Receive 2018 MedTech Insight Award for Best Alliance - Insights
WuXi Diagnostics, a joint venture between WuXi AppTec Group and Mayo Clinic, recently received the 2018 MedTech Insight Award for the Best Alliance.
Applying the Staffing-to-Workload Methodology: On-Site and Off-Site Operational Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses the inclusion of on-site and off-site operational needs of the laboratory in his staffing-to-workload analysis.
A letter of appreciation, which was forwarded to Mayo Clinic President and CEO John Noseworthy, M.D., and Board of Trustees member Samual Di Piazza, Jr., described the outstanding contributions to science and education that Mayo Clinic DLMP...